Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bienfait, H. P."'
Autor:
Kuhrij, Laurien S., Marang-van de Mheen, Perla J., van den Berg-Vos, Renske M., de Leeuw, Frank-Erik, Nederkoorn, Paul J., Lingsma, H. F., de Borst, G. J., van Norden, A. G. W., Eysink Smeets, M. M., Aerden, L. A. M., Alblas, C. L., de Beer, F., Bienfait, H. P., Boon, A. E., Bor, S., Boreas, A. M. H. P., Bronner, I., Brouns, R., Brouwers, P. J. A. M., Brugman, F., Dane, M. L., Fransen, P. S. S., van Gemert, H. M. A., van Golde, A. E. L., de Graaf, M. T., Hani, L., van der Heijden, A. M. H. G., Hilkens, P. H., ten Holter, J. B. M., de Jong, S. W., Kapelle, L. J., Keizer, K., Keunen, R., Kloppenborg, R. P., Kok, A. J. M., Koops, L., Kruyt, N. D., de Leeuw, F. E., Lövenich, H., Luijckx, G. J., Maasland, E., Miedema, I., Nederkoorn, P. J., Persoon, S., Peters, E. W., van der Ree, T. C., Rozeman, A. D., Saxena, R., van Schaik, S., de Schryver, E. L. L. M., Schuiling, W. J., Schut, E. S., Staals, J. E. A., Stalpers, X., Tjeerdsma, H., van Tuijl, J. H., Vermeer, S. E., Visser, M. C., van den Wijngaard, I., van Zagten, M. S. G., Zylicz, S. A.
Publikováno v:
BMC neurology, 19(1):265. BioMed Central
BMC Neurology, 19(1):265. BioMed Central Ltd
BMC Neurology
BMC Neurology, 19, 1
BMC Neurology, Vol 19, Iss 1, Pp 1-8 (2019)
BMC NEUROLOGY, 19(1):265. BioMed Central Ltd.
BMC Neurology, 19(1). BMC
BMC Neurology, 19
BMC Neurology, 19(1):265. BioMed Central Ltd
BMC Neurology
BMC Neurology, 19, 1
BMC Neurology, Vol 19, Iss 1, Pp 1-8 (2019)
BMC NEUROLOGY, 19(1):265. BioMed Central Ltd.
BMC Neurology, 19(1). BMC
BMC Neurology, 19
Background Intravenous thrombolysis (IVT) plays a prominent role in the treatment of acute ischemic stroke (AIS). The sooner IVT is administered, the higher the odds of a good outcome. Therefore, registering the in-hospital time to treatment with IVT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b802ad48976e535dc1c1815ee2fbaae7
https://pure.amc.nl/en/publications/determinants-of-extended-doortoneedle-time-in-acute-ischemic-stroke-and-its-influence-on-inhospital-mortality-results-of-a-nationwide-dutch-clinical-audit(62e62003-7340-4cd2-aa5f-4e4a1d04ad2f).html
https://pure.amc.nl/en/publications/determinants-of-extended-doortoneedle-time-in-acute-ischemic-stroke-and-its-influence-on-inhospital-mortality-results-of-a-nationwide-dutch-clinical-audit(62e62003-7340-4cd2-aa5f-4e4a1d04ad2f).html
Autor:
Zinkstok, Sanne M., Roos, Yvo B., Aerden, L. A. M., van den Berg-Vos, R. M., Bakker, S. L. M., Bienfait, H. M. E., Bienfait, H. P., Boon, A. E., Brans, J. W. M., Bronner, I. M., de Bruijn, S. F. T. M., Franke, C. L., Hofstee, D. J., Jansen, B. P. W., Jellema, K., Kalkers, N. F., Portegies, P., Keizer, K., Kerkhoff, H., de Gans, K., Kloos, L. M. H., Kok, A. J. M., de Kort, P. L. M., de Kruijk, J. R., van der Kruijk, R. A., Kwa, V. I. H., Kruyt, N. D., Meijer, R. J., van der Meulen, W. D. M., Mulleners, W. M., Nederkoorn, P. J., van der Ree, T. C., Rooyer, F. A., Saxena, R., Schuiling, W. J., Verbiest, H. B. C., Verhey, J. C. B., Vermeer, S. E., Visée, H. F., Visser, M. C., van der Wiel, H. L., van der Worp, H. B., de Haan, R. J., Stam, J., Vermeulen, M., Peters, R. J. G., Majoie, C. B. L. M., Beenen, L. F., Marquering, H. A., van Geloven, N.
Publikováno v:
Lancet, 380(9843), 731-737. Elsevier Science
Lancet, 380(9843), 731-737. Elsevier Limited
Lancet, 380(9843), 731-737. Elsevier Limited
Summary Background Thrombolysis with intravenous alteplase is the only approved treatment for acute ischaemic stroke. After alteplase-induced recanalisation, reocclusion occurs in 14–34% of patients, probably because of platelet activation. Early a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::224add775a4f7ebfeab23fc707fd3845
https://cris.maastrichtuniversity.nl/en/publications/0c2e15bb-3dbf-42b1-826d-76a83588bc51
https://cris.maastrichtuniversity.nl/en/publications/0c2e15bb-3dbf-42b1-826d-76a83588bc51